Showing results (2531-2540 of 3,978) with videos related to
Sort By:
Pageof 398
European Journal of Heart Failure|August 7, 2009
Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hopeThanh Trung Phan, Ganesh Nallur Shivu, Anirban Choudhury, et al.European Journal of Heart Failure|April 30, 2010
Bone marrow dysfunction in chronic heart failure patientsB Daan Westenbrink, Adriaan A Voors, Rudolf A de Boer, et al.European Journal of Heart Failure|April 22, 2010
New insights into paracrine mechanisms of human cardiac progenitor cellsHagen Maxeiner, Nina Krehbiehl, Andrea Müller, et al.European Journal of Heart Failure|April 22, 2010
Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell deathChristiane Malfitano, Tatiana C Alba Loureiro, Bruno Rodrigues, et al.European Journal of Heart Failure|May 4, 2010
Cardiac resynchronization therapy for the causal treatment of heart failure with preserved ejection fraction: insight from a pressure-volume loop analysisMartin Penicka, Viktor Kocka, Dalibor Herman, et al.European Journal of Heart Failure|June 29, 2010
Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcomeStephanie Kiencke, Rolf Handschin, Ruth von Dahlen, et al.European Journal of Heart Failure|August 28, 2010
Plasma parathyroid hormone and risk of congestive heart failure in the communityEmil Hagström, Erik Ingelsson, Johan Sundström, et al.European Journal of Heart Failure|August 30, 2011
The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiographyMiriam Shanks, M Louisa Antoni, Ulas Hoke, et al.European Journal of Heart Failure|August 30, 2011
A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failureGerrit Frommeyer, Peter Milberg, Patricia Witte, et al.European Journal of Heart Failure|August 12, 2011
Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory settingGavin Y Oudit, Jeffrey A Bakal, Finlay A McAlister, et al.Pageof 398